Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207386 · ClinicalTrials.gov registry record · NA
Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative
A NA study, sponsored by University of New Hampshire.
- Completed
- Registry status
- NA
- Development phase
- 2,647
- Enrollment target
NCT03207386: Completed NA study, sponsored by University of New Hampshire.
NCT03207386 is a NA study that has completed, run by University of New Hampshire. The registered enrollment target is 2,647 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207386, a NA study, has completed, sponsored by University of New Hampshire.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,647 participants
- Enrollment target
Study Summary
The purpose of this multiple baseline study is to evaluate the effectiveness of a comprehensive youth-led sexual violence (SV) prevention program, Youth Voices in Prevention (Youth VIP). The prevention program builds on youth-adult partnerships among middle and high school students in Rapid City, South Dakota. Consenting students will take part in a youth summit where they will be trained as popular opinion leaders to spread SV prevention messages among middle and high school youth and parents. Following the summit, youth will work in small groups focused on different aspects of evidence-based prevention strategies including bystander intervention, social marketing messaging, parent education, norms change, and social emotional learning. Multiple research methods will be used to examine implementation process and cost. In addition, consenting students will take six surveys across three years including several surveys before programming begins, and several to document Youth VIP outcomes after prevention programming takes place. Survey data from a demographically similar community will be used to assess changes over time among youth in Rapid City, SD. All phases of the project will be implemented with collaboration from a Research Programming Advisory Board of community members and professionals from Rapid City, SD.
Primary Outcome
We used several measures to assess for a wide range of interpersonal violence victimization perpetration experiences during the past six months, all with response options 1 = yes or 0 = no. Outcome counts indicate number of participants who reported yes to any form of sexual violence perpetration. We used mirror items to assess for both victimization and perpetration experiences. Three items assessing sexual assault were drawn from Cook-Craig et al.'s (2014) measure that assessed for sexual coer
Interventions
- BEHAVIORAL Youth VIP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,647 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
What the finished NCT03207386 record still lists
NCT03207386 is an interventional study that assigns participants to a tested intervention. Its 2,647 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% higher).
The record links to 0 conditions, and to 1 intervention - of which Youth VIP is the first listed.
NCT03207386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207386 about?
NCT03207386 is a clinical study titled "Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative". The purpose of this multiple baseline study is to evaluate the effectiveness of a comprehensive youth-led sexual violence (SV) prevention program, Youth Voices in Prevention (Youth VIP). The prevention program builds on youth-adult partnerships among middle and high school students in Rapid City, So...
What is the current status of trial NCT03207386?
This trial is currently completed. It is a NA study. The enrollment target is 2,647 participants. The study started on 2017-02-27. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03207386?
The interventions under investigation include: Youth VIP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03207386?
This trial is sponsored by University of New Hampshire, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03207386's enrollment target sits among peer trials
2,647 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI